Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1005724.RAZtYBay8Eg2bKXRfIHspEs_cBLe6QxjgVXsqnruHeA6U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1005724.RAZtYBay8Eg2bKXRfIHspEs_cBLe6QxjgVXsqnruHeA6U130_assertion type Assertion NP1005724.RAZtYBay8Eg2bKXRfIHspEs_cBLe6QxjgVXsqnruHeA6U130_head.
- NP1005724.RAZtYBay8Eg2bKXRfIHspEs_cBLe6QxjgVXsqnruHeA6U130_assertion wasGeneratedBy ECO_0000203 NP1005724.RAZtYBay8Eg2bKXRfIHspEs_cBLe6QxjgVXsqnruHeA6U130_provenance.
- NP1005724.RAZtYBay8Eg2bKXRfIHspEs_cBLe6QxjgVXsqnruHeA6U130_assertion wasDerivedFrom befree-2016 NP1005724.RAZtYBay8Eg2bKXRfIHspEs_cBLe6QxjgVXsqnruHeA6U130_provenance.
- NP1005724.RAZtYBay8Eg2bKXRfIHspEs_cBLe6QxjgVXsqnruHeA6U130_assertion SIO_000772 22898604 NP1005724.RAZtYBay8Eg2bKXRfIHspEs_cBLe6QxjgVXsqnruHeA6U130_provenance.
- NP1005724.RAZtYBay8Eg2bKXRfIHspEs_cBLe6QxjgVXsqnruHeA6U130_assertion evidence source_evidence_literature NP1005724.RAZtYBay8Eg2bKXRfIHspEs_cBLe6QxjgVXsqnruHeA6U130_provenance.
- NP1005724.RAZtYBay8Eg2bKXRfIHspEs_cBLe6QxjgVXsqnruHeA6U130_assertion description "[Our studies demonstrate that inhibitors of autophagy or cathepsin B activity and/or molecular targeting of p62/SQSTM1, Atg7, or cathepsin B result in partial reversal of the suppressive effects of AS(2)O(3) on BCR-ABL expressing leukemic progenitors, including primitive leukemic precursors from chronic myelogenous leukemia (CML) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005724.RAZtYBay8Eg2bKXRfIHspEs_cBLe6QxjgVXsqnruHeA6U130_provenance.